IT8621097A1 - Derivato di timo attivo per via orale, procedimenti per la sua preparazione e relative composizioni farmaceutiche - Google Patents

Derivato di timo attivo per via orale, procedimenti per la sua preparazione e relative composizioni farmaceutiche

Info

Publication number
IT8621097A1
IT8621097A1 IT1986A21097A IT2109786A IT8621097A1 IT 8621097 A1 IT8621097 A1 IT 8621097A1 IT 1986A21097 A IT1986A21097 A IT 1986A21097A IT 2109786 A IT2109786 A IT 2109786A IT 8621097 A1 IT8621097 A1 IT 8621097A1
Authority
IT
Italy
Prior art keywords
thyme
derivative
procedures
preparation
pharmaceutical compositions
Prior art date
Application number
IT1986A21097A
Other languages
English (en)
Other versions
IT1196958B (it
IT8621097A0 (it
Original Assignee
Ellem Ind Farmaceutica
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ellem Ind Farmaceutica filed Critical Ellem Ind Farmaceutica
Publication of IT8621097A0 publication Critical patent/IT8621097A0/it
Priority to IT21097/86A priority Critical patent/IT1196958B/it
Priority to AR87307819A priority patent/AR244243A1/es
Priority to US07/060,446 priority patent/US4904643A/en
Priority to AU75364/87A priority patent/AU604717B2/en
Priority to KR1019870007388A priority patent/KR930000055B1/ko
Priority to EP87109936A priority patent/EP0259564A3/en
Priority to CA000541789A priority patent/CA1310266C/en
Priority to JP62171338A priority patent/JP2579771B2/ja
Publication of IT8621097A1 publication Critical patent/IT8621097A1/it
Application granted granted Critical
Publication of IT1196958B publication Critical patent/IT1196958B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/26—Lymph; Lymph nodes; Thymus; Spleen; Splenocytes; Thymocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/837—Lymph; lymph-glands; thymus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/854—Glands

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IT21097/86A 1986-07-10 1986-07-10 Derivato di timo attivo per via orale, procedimenti per la sua preparazione e relative composizioni farmaceutiche IT1196958B (it)

Priority Applications (8)

Application Number Priority Date Filing Date Title
IT21097/86A IT1196958B (it) 1986-07-10 1986-07-10 Derivato di timo attivo per via orale, procedimenti per la sua preparazione e relative composizioni farmaceutiche
AR87307819A AR244243A1 (es) 1986-07-10 1987-06-09 Procedimiento para preparar timolinfotropina.
US07/060,446 US4904643A (en) 1986-07-10 1987-06-11 Thymus derivative active after oral administration, methods of preparation and pharmaceutical compositions
AU75364/87A AU604717B2 (en) 1986-07-10 1987-07-08 A thymus derivative active after oral administration, methods of preparation and pharmaceutical compositions
KR1019870007388A KR930000055B1 (ko) 1986-07-10 1987-07-09 경구투여후 활성을 가진 흉선 유도체 및 그 제조방법 및 제약조성물
EP87109936A EP0259564A3 (en) 1986-07-10 1987-07-09 A thymus derivative active after oral administration, methods of preparation and pharmaceutical compositions
CA000541789A CA1310266C (en) 1986-07-10 1987-07-10 Thymus derivative active after oral administration, methods of preparation and pharmaceutical compositions
JP62171338A JP2579771B2 (ja) 1986-07-10 1987-07-10 胸腺抽出物、その製造方法及びそれを含む薬剤組成物

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT21097/86A IT1196958B (it) 1986-07-10 1986-07-10 Derivato di timo attivo per via orale, procedimenti per la sua preparazione e relative composizioni farmaceutiche

Publications (3)

Publication Number Publication Date
IT8621097A0 IT8621097A0 (it) 1986-07-10
IT8621097A1 true IT8621097A1 (it) 1988-01-10
IT1196958B IT1196958B (it) 1988-11-25

Family

ID=11176692

Family Applications (1)

Application Number Title Priority Date Filing Date
IT21097/86A IT1196958B (it) 1986-07-10 1986-07-10 Derivato di timo attivo per via orale, procedimenti per la sua preparazione e relative composizioni farmaceutiche

Country Status (8)

Country Link
US (1) US4904643A (it)
EP (1) EP0259564A3 (it)
JP (1) JP2579771B2 (it)
KR (1) KR930000055B1 (it)
AR (1) AR244243A1 (it)
AU (1) AU604717B2 (it)
CA (1) CA1310266C (it)
IT (1) IT1196958B (it)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5807830A (en) * 1987-12-30 1998-09-15 Cytoven J.V. Method for treatment of purulent inflammatory diseases
US5728680A (en) 1987-12-30 1998-03-17 Cytoven J.V. Methods for normalizing numbers of lymphocytes
US5811399A (en) * 1988-12-14 1998-09-22 Cytran, Inc. Pharmaceutical dipeptide compositions and methods of use thereof: immunodepressants
US5770576A (en) * 1989-08-30 1998-06-23 Cytran, Inc. Pharmaceutical dipeptide compositions and methods of use thereof: systemic toxicity
US6100380A (en) * 1991-10-28 2000-08-08 Cytran, Inc. Immunomodulating peptides and methods of use
US6066622A (en) 1991-10-28 2000-05-23 Cytran, Inc. Immunomodulating peptides and methods of use
CA2131709C (en) * 1992-03-13 2004-11-23 Terry R. Beardsley Immune-enhancing agent for therapeutic use in immunocompromised hosts
DE19622422A1 (de) * 1996-06-04 1997-12-11 Sanorell Pharma Gmbh & Co Lagerungsstabile pharmazeutische Zusammensetzung mit immun - modulierenden und antiinflammatorischen Eigenschaften sowie ein Verfahren zu dessen Herstellung

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1195980A (en) * 1966-08-24 1970-06-24 Univ Yeshiva Hormone-Like Preparations Derived from Thymus Gland and Methods of Producing the Same.
US3657417A (en) * 1969-05-26 1972-04-18 Lab Farmaco Biolog Ellem Spa Thymus extract having a therapeutic action
FR2047884A1 (en) * 1969-06-24 1971-03-19 Lab Farmaco Biol Anti-leukopenic partially-lysed thymus - extract
US4077949A (en) * 1973-12-28 1978-03-07 Sloan-Kettering Institute For Cancer Research Polypeptide hormones of the thymus
IL47645A (en) * 1975-07-04 1980-10-26 Yeda Res & Dev Substantially pure and uniform thymic hormone thf,its preparation and pharmaceutical compositions containing it
US4120951A (en) * 1975-08-22 1978-10-17 Sloan-Kettering Institute For Cancer Research Polypeptide hormones of the thymus
US4215112A (en) * 1979-03-14 1980-07-29 Ortho Pharmaceutical Corporation Tripeptides and methods
SE448605B (sv) * 1980-10-27 1987-03-09 Vtoroi Mo G Med I Imen Terapeutiskt preparat for reglering av t-immunsystemet och forfarande for framstellning derav
US4374828A (en) * 1980-11-17 1983-02-22 Board Of Reagents, The University Of Texas System Biologically active thymones from the thymus
US4388234A (en) * 1981-12-28 1983-06-14 Hoffmann-La Roche Inc. Peptide isolation
DE3230151A1 (de) * 1982-08-13 1984-02-16 Hoechst Ag, 6230 Frankfurt Neues polypeptid mit wirkung auf das immunsystem, verfahren zu seiner isolierung und reinigung, seine verwendung, dieses enthaltende mittel sowie seine spaltprodukte, deren verwendung und diese enthaltende mittel
WO1984001090A1 (en) * 1982-09-20 1984-03-29 Endorphin Inc Immune stimulator
US4571336A (en) * 1983-08-25 1986-02-18 Endorphin, Inc. Immune stimulation
CH659586A5 (de) * 1985-07-02 1987-02-13 Le G Ped I Arzneimittel aus dem thymus und verfahren zu dessen herstellung.
DE3672950D1 (de) * 1985-10-23 1990-08-30 Mulli Kurt Nachf Gmbh Thymusextraktfraktionen enthaltende pharmazeutische zusammensetzung.
CA1320906C (en) * 1986-06-04 1993-08-03 Daniel R. Twardzik Interleukin-2 induced antineoplastic peptide
JPS6490199A (en) * 1987-09-30 1989-04-06 Hiromi Fujiwara T cell growth factor derived from thymic interstitial cell and production thereof

Also Published As

Publication number Publication date
CA1310266C (en) 1992-11-17
IT1196958B (it) 1988-11-25
EP0259564A2 (en) 1988-03-16
IT8621097A0 (it) 1986-07-10
KR930000055B1 (ko) 1993-01-06
AU604717B2 (en) 1991-01-03
EP0259564A3 (en) 1989-09-27
JP2579771B2 (ja) 1997-02-12
AR244243A1 (es) 1993-10-29
JPS6388200A (ja) 1988-04-19
US4904643A (en) 1990-02-27
KR880001702A (ko) 1988-04-26
AU7536487A (en) 1988-01-14

Similar Documents

Publication Publication Date Title
IT8619675A0 (it) Formulazioni per la preparazione di farmaci a rilascio prolungato adatte alla somministrazione per via orale.
IT8423523A0 (it) Procedimento e composizione per lapreparazione di prodotti farmaceutici ad azione prolungata controllata per la somministrazione orale.
DZ1077A1 (fr) Nouvelles préparation pharmaceutique pour administration orale.
IL83349A (en) Stable pharmaceutical composition comprising cimetidine polymorph b suitable for oral administration
FI872733L (fi) Farmaceutiska kompositioner.
IT8767057A0 (it) Composizioni farmaceutiche a cessione prolungata relative forme di dosaggio e procedimento per la loro preparazione
IT8621097A0 (it) Composizioni farmaceutiche. derivato di timo attivo per via orale, procedimenti per la sua preparazione e relative
FI873800A7 (fi) Nor-kolaanihappojohdannaiset, menetelmä niiden valmistamiseksi, niiden käyttö sekä niitä sisältävät farmaseuttiset seokset.
IT1228437B (it) "derivati di 2,3,4,5,6,7 esaidro 2,7-metano-1,5 benzossazonina (rispettivamente 1,4 benzossazonina), procedimento per la loro preparazione e prodotti medicinali che contengono questi composti.
IT8821570A0 (it) Impiego di derivati adenosinici per la preparazione di composizioni farmaceutiche aventi attivita' immunostimolante.
DE3761561D1 (de) N,n-bis-(4-fluorophenyl)carbamoylacetohydroxamsaeure und diese enthaltende pharmazeutische zusammensetzungen.
IT8721958A0 (it) Derivato di taurina, sua preparazione e composizioni farmaceutiche relative
IT8648677A0 (it) Lisato antigenico batterico,procedimento per la sua preparazione e composizioni farmaceutiche che lo contengono
FI870787A7 (fi) Puhdistettu ihmisen angiogeeninen tekijä, menetelmä sen valmistamiseksi ja farmaseuttisia koostumuksia.
DE3768109D1 (de) Pharmazeutische zusammensetzungen.
IT8747852A0 (it) Benzammidi sostituite, procedimento per la loro preparazione e composizioni farmaceutiche che le contengono
IT8622105A0 (it) Formulazioni idrosolubili di ubidecarenoni, procedimento per laloro preparazione e composizioni farmaceutiche che li compongono.
IT1210868B (it) Derivati della cefuroxima attivi per via orale procedimenti per laloro preparazione e relative composizioni farmaceutuche.
IT8622783A0 (it) Derivati imidazolici adattivita' terapeutica, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.
IT8125374A0 (it) Composto antiipertensivo procedimento per la sua preparazione e relative composizioni farmaceutiche.
IT8103450A0 (it) Preparazione e relative fosfato di creatina modificato composizioni farmaceutiche adatto per la somministrazione orale, metodi per la sua
IT1216894B (it) Composizione farmaceutica eprocedimento per la sua preparazione.
IL81926A0 (en) Pharmaceutical compositions for the oral administration of active proteins
IT8619751A0 (it) Composizioni farmaceutiche contenenti vinburnina e loro procedimento di preparazione.
IT8721157A0 (it) Composto terapeuticamente utile, procedimento per la sua preparazione e relative composizioni farmaceutiche.

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19960725